Tseng HC et al (2023) Involvement of antioxidant and Prevention of mitochondrial Dysfunction, Anti-neuroinflammatory Effect and Anti-apoptotic Effect: Betaine ameliorates Haloperidol-Induced Orofacial Dyskinesia in rats. Brain Sci, 13(7)

Sabry HA, Zahra MM (2024) Icariin attenuates dopaminergic neural loss in haloperidol-induced parkinsonism in rats via GSK-3β and tyrosine hydroxylase regulation mechanism. J Chem Neuroanat 136:102385

Article  CAS  PubMed  Google Scholar 

Kadir A et al (2022) Berberine ameliorate haloperidol and 3-Nitropropionic acid-induced neurotoxicity in rats. Neurochem Res 47(11):3285–3297

Article  CAS  PubMed  Google Scholar 

Yedke NG et al (2023) Bacillus Calmette-Guérin vaccine attenuates Haloperidol-Induced TD-like behavioral and neurochemical alteration in experimental rats. Biomolecules, 13(11)

Kong CH et al (2023) Oleanolic acid alleviates the extrapyramidal symptoms and cognitive impairment induced by haloperidol through the striatal PKA signaling pathway in mice. Biomed Pharmacother 168:115639

Article  CAS  PubMed  Google Scholar 

Wang MH et al (2021) Naringin ameliorates Haloperidol-Induced neurotoxicity and Orofacial Dyskinesia in a rat model of human Tardive Dyskinesia. Neurotox Res 39(3):774–786

Article  CAS  PubMed  Google Scholar 

Tsai CC et al (2019) Possible nitric oxide mechanism involved in the protective effect of L-theanine on haloperidol-induced orofacial dyskinesia. Chin J Physiol 62(1):17–26

Article  CAS  PubMed  Google Scholar 

Singh A, Naidu PS, Kulkarni SK (2003) Possible antioxidant and neuroprotective mechanisms of FK506 in attenuating haloperidol-induced orofacial dyskinesia. Eur J Pharmacol 477(2):87–94

Article  CAS  PubMed  Google Scholar 

Thakur KS et al (2015) Beneficial effect of candesartan and lisinopril against haloperidol-induced tardive dyskinesia in rat. J Renin-Angiotensin-Aldosterone Syst 16(4):917–929

Article  CAS  PubMed  Google Scholar 

Lister J et al (2017) Lipoic acid and haloperidol-induced vacuous chewing movements: implications for prophylactic antioxidant use in tardive dyskinesia. Prog Neuropsychopharmacol Biol Psychiatry 72:23–29

Article  CAS  PubMed  Google Scholar 

Wang M-H et al (2021) Naringin ameliorates haloperidol-induced neurotoxicity and orofacial dyskinesia in a rat model of human tardive dyskinesia. Neurotox Res 39:774–786

Article  CAS  PubMed  Google Scholar 

Samad N, Haleem DJ (2017) Antioxidant effects of rice bran oil mitigate repeated haloperidol-induced tardive dyskinesia in male rats. Metab Brain Dis 32:1099–1107

Article  CAS  PubMed  Google Scholar 

Mezzomo NF et al (2022) Reversal of haloperidol-induced orofacial dyskinesia and neuroinflammation by isoflavones. Mol Biol Rep, p. 1–7

Dhingra D, Goswami S, Gahalain N (2018) Protective effect of hesperetin against haloperidol-induced orofacial dyskinesia and catalepsy in rats. Nutr Neurosci 21(9):667–675

Article  PubMed  Google Scholar 

Yi TT, Zhang LM, Huang XN (2023) Glycyrrhizic acid protects against temporal lobe epilepsy in young rats by regulating neuronal ferroptosis through the miR-194-5p/PTGS2 axis. Kaohsiung J Med Sci 39(2):154–165

Article  CAS  PubMed  Google Scholar 

Docimo T et al (2024) Exploring influence of production area and Harvest Time on Specialized Metabolite Content of Glycyrrhiza glabra leaves and evaluation of antioxidant and Anti-aging Properties. Antioxid (Basel), 13(1)

Gendy AM et al (2023) Glycyrrhizin prevents 3-nitropropionic acid-induced neurotoxicity by downregulating HMGB1/TLR4/NF-κB p65 signaling, and attenuating oxidative stress, inflammation, and apoptosis in rats. Life Sci 314:121317

Article  CAS  PubMed  Google Scholar 

Zhang Y et al (2024) Paeonol and glycyrrhizic acid in combination ameliorate the recurrent nitroglycerin-induced migraine-like phenotype in rats by regulating the GABBR2/TRPM8/PRKACA/TRPV1 pathway. J Ethnopharmacol, p. 118464

Ma S et al (2024) Glycyrrhizic acid treatment ameliorates anxiety-like behaviour via GLT1 and Per1/2-dependent pathways. J Ethnopharmacol 328:118013

Article  CAS  PubMed  Google Scholar 

Ojha S et al (2016) Glycyrrhizic acid attenuates neuroinflammation and oxidative stress in rotenone model of Parkinson’s disease. Neurotox Res 29:275–287

Article  CAS  PubMed  Google Scholar 

Yang G et al (2018) Glycyrrhizic acid alleviates 6-Hydroxydopamine and corticosterone-Induced neurotoxicity in SH-SY5Y cells through modulating Autophagy. Neurochem Res 43(10):1914–1926

Article  CAS  PubMed  Google Scholar 

Ban JY, Park HK, Kim SK (2020) Effect of Glycyrrhizic Acid on Scopolamine-Induced Cognitive Impairment in mice. Int Neurourol J 24(Suppl 1):S48–55

Article  PubMed  PubMed Central  Google Scholar 

Cao Z-Y et al (2020) Glycyrrhizic acid as an adjunctive treatment for depression through anti-inflammation: a randomized placebo-controlled clinical trial. J Affect Disord 265:247–254

Article  CAS  PubMed  Google Scholar 

Kouranov A et al (2006) The RCSB PDB information portal for structural genomics. 34(suppl1):D302–D305

Bell J et al (2012) PrimeX and the Schrödinger computational chemistry suite of programs

Devi B, Jangid K, Kumar N. et al (2024) Identification of potential JNK3 inhibitors through virtual screening, molecular docking and molecular dynamics simulation as therapeutics for Alzheimer’s disease. Mol Divers 28:4361–4380

Devi B, Jangid K, Kumar V, Arora T, Kumar N, Dwivedi AR,... & Kumar V (2024) Phenylstyrylpyrimidine derivatives as potential multipotent therapeutics for Alzheimer's disease. RSC Med Chem 15(8):2922–2936

Friesner RA et al (2004) Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. 47(7):1739–1749

Van Der Spoel D et al (2005) GROMACS: fast, flexible, and free. 26(16):1701–1718

Jangid K et al (2024) Virtual screening and molecular dynamics simulation approach for the identification of potential multi-target directed ligands for the treatment of Alzheimer’s disease. 42(1):509–527

Jangid K et al (2024) Discovery of Small-Molecules as Potential GSK‐3β Inhibitors for the Treatment of Alzheimer’s Disease Using Pharmacophore‐Based Virtual Screening. 9(15):e202400808

Devi B et al (2024) Identification of potential JNK3 inhibitors through virtual screening, molecular docking and molecular dynamics simulation as therapeutics for Alzheimer’s disease. pp. 1–20

Jangid K et al (2023) Virtual screening and molecular dynamics simulation approach for the identification of potential multi-target directed ligands for the treatment of Alzheimer’s disease. J Biomol Struct Dynamics, p. 1–19

Ding Y et al (2020) α-Arbutin protects against Parkinson’s disease-associated mitochondrial dysfunction in vitro and in vivo. Neuromol Med 22:56–67

Article  CAS  Google Scholar 

Huang B et al (2020) α-Cyperone attenuates H2O2-induced oxidative stress and apoptosis in SH-SY5Y cells via activation of Nrf2. Front Pharmacol 11:281

Article  PubMed  PubMed Central  Google Scholar 

Yedke NG et al (2023) Bacillus Calmette–Guérin vaccine attenuates Haloperidol-Induced TD-like behavioral and neurochemical alteration in experimental rats. Biomolecules 13(11):1667

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhu JR et al (2018) Berberine attenuates ischemia-reperfusion injury through inhibiting HMGB1 release and NF-κB nuclear translocation. Acta Pharmacol Sin 39(11):1706–1715

Article  CAS  PubMed  PubMed Central  Google Scholar 

González-Reyes S et al (2016) Glycyrrhizin ameliorates oxidative stress and inflammation in hippocampus and olfactory bulb in lithium/pilocarpine-induced status epilepticus in rats. Epilepsy Res 126:126–133

Article  PubMed  Google Scholar 

Yi TT, Zhang LM, Huang XN (2023) Glycyrrhizic acid protects against temporal lobe epilepsy in young rats by regulating neuronal ferroptosis through the miR-194‐5p/PTGS2 axis. Kaohsiung J Med Sci 39(2):154–165

Article  CAS  PubMed  Google Scholar 

Datta S et al (2016) Beneficial effects of lycopene against haloperidol induced orofacial dyskinesia in rats: possible neurotransmitters and neuroinflammation modulation. Eur J Pharmacol 771:229–235

Article  CAS  PubMed  Google Scholar 

Jamwal S, Kumar P (2016) Spermidine ameliorates 3-nitropropionic acid (3-NP)-induced striatal toxicity: possible role of oxidative stress, neuroinflammation, and neurotransmitters. Physiol Behav 155:180–187

Article  CAS  PubMed  Google Scholar 

Kumar P, Kumar A (2009) Possible neuroprotective effect of Withania somnifera root extract against 3-nitropropionic acid-induced behavioral, biochemical, and mitochondrial dysfunction in an animal model of Huntington’s disease. J Med Food 12(3):591–600

Article  CAS  PubMed  Google Scholar 

Rahi V, Ram P, KUMAR P (2021) Neuroprotective effect of Filgrastim in Animal models of 3-Nitropropionic Acid. & Haloperidol Induced Neurotoxicity in Rats

Kono Y (1978) Generation of superoxide radical during autoxidation of hydroxylamine and an assay for superoxide dismutase. Arch Biochem Biophys 186(1):189–195

Article  CAS  PubMed  Google Scholar 

Singh G et al (2022) Neuroprotection by arbutin against haloperidol-induced Tardive Dyskinesia in rats and reducing neurotoxicity in SHSY-5Y cells

Papadopoulos F et al (2020) Haloperidol induced cell cycle arrest and apoptosis in glioblastoma cells. Biomedicines 8(12):595